Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of Achilles Therapeutics plc from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Achilles Therapeutics plc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q4 2021 to Q2 2024.
  • Achilles Therapeutics plc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Jun 2024 was $197K, a 61.1% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2024 $197K -$309K -61.1% 30 Jun 2024 6-K 14 Aug 2024
Q4 2023 $201K -$311K -60.7% 31 Dec 2023 20-F 04 Apr 2024
Q2 2023 $506K 30 Jun 2023 6-K 04 Aug 2023
Q4 2022 $512K -$386K -43% 31 Dec 2022 20-F 07 Mar 2023
Q4 2021 $898K 31 Dec 2021 20-F 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.